UAE Diabetes Market Opportunity Sales Revenue Opportunity Report 2018

UAE, with one of the highest rates of Type 2 diabetes represents significant societal costs, in relation to morbidity, mortality and also lost productivity coupled with a huge burden on the healthcare system. It has been observed that the high prevalence of diabetes in the UAE is gradually taking its toll on the overall health of the nation and also risking the country’s economic well-being.

Download Report:

https://www.kuickresearch.com/report-UAE-Diabetes-Market-Opportunity-Analysis-2018.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"UAE Diabetes Market Opportunity Analysis 2018" Table of Contents

1. UAE Diabetes Market Overview
1.1 Market Overview
1.2 Diabetes Incidence

2. UAE Diabetes Market Dynamics
2.1 Market Drivers
2.2 Challenges to be Resolved
2.3 Future Opportunities

3. UAE Diabetes Drug Market
3.1 Oral
3.2 Insulin

4. UAE Insulin Delivery Devices Market
4.1 Pens
4.2 Syringes

5. UAE Glucose Monitoring Devices Market

6. Competitive Market
6.1 Gulf Pharmaceutical Industries (Julphar Diabetes)
6.2 Eli Lilly
6.3 Novo Nordisk
6.4 Medysinal Fze
6.5 Sanofi-Aventis

Figure 1-1: Total Medical Cost for All Types of Diabetes (US$ Million), 2012-2018
Figure 1-2: Medical Cost for Type 2 Diabetes (US$ Million), 2012-2018
Figure 1-3: Medical Cost for Type-1 Diabetes (US$ Million), 2012-2018
Figure 1-4: Medical Cost for Undiagnosed Diabetes (US$ Million), 2012-2018
Figure 1-5: Diabetes Prevalence (%), 2012 & 2030
Figure 1-6: UAE v/s GCC Countries Diabetes Prevalence, 2012
Figure 1-7: Number of Type 2 Diabetes Cases (‘000), 2012-2018
Figure 1-8: Number of Type 1 Diabetes Cases (‘000), 2012-2018
Figure 1-9: Number of Undiagnosed Diabetes Cases (‘000), 2012-2018
Figure 1-10: Type-2 Diabetes Prevalence in Age Group 20-79 (%)
Figure 2-1: Factor Driving Diabetes Prevalence
Figure 2-2: Challenges for Diabetes Market
Figure 3-1: Oral Insulin Market (US$ Million), 2012-2018
Figure 3-2: Insulin Device (US$ Million), 2012-2018
Figure 4-1: Insulin Pen Market (US$ Million), 2012-2018
Figure 4-2: Insulin Syringe Market (US$ Million), 2012-2018
Figure 5-1: Glucose Monitoring Devices Market (US$ Million), 2012-2018

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.